Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/04/065382
CTRI/2024/04/065382
Not yet recruiting
Phase 4

A comparative study to evaluate the efficacy and safety of oral tranexamic acid with triple combination cream versus triple combination cream monotherapy in the treatment of Melasma

MOHAN H 0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L814- Other melanin hyperpigmentation

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L814- Other melanin hyperpigmentation
Sponsor
MOHAN H
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
MOHAN H

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients willing to give informed consent
  • •2\. Patients of either gender aged more than 18 years
  • •3\. Patients willing for follow up
  • •4\. Patients with clinically diagnosed melasma

Exclusion Criteria

  • •1\. Patient not willing to give informed consent
  • •2\. Patient already on melasma treatment with topical therapy within 2 weeks.
  • •3\. Pregnant and lactating females.
  • •4\. History of coexisting endocrinopathies.
  • •5\. History of thrombosis, thromboembolic episodes and altered blood coagulation profile.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Comparison of efficacy and safety of Vortioxetine and Escitalopram in depressive patients.Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
CTRI/2023/12/060661Ronakkumar Chandubhai Patel
Not yet recruiting
Not Applicable
Iron deficiency anemia treatment in adults: comparing daily versus alternate day iron regimens
CTRI/2024/03/064861Viswanathan S
Not yet recruiting
Not Applicable
A study to compare two drugs Seratconazole versus Luliconacole for improvement of symptoms and to compare the side effectsHealth Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecifiedHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
CTRI/2022/10/046157Yuvarani R
Not yet recruiting
Not Applicable
Comparison study to evaluate the efficacy and safety of a topical gel
CTRI/2024/08/072002Abbott India Limited
Not yet recruiting
Not Applicable
Safety and effectiveness of rosuvastatin versus rosuvastatin with fenofibrate in patients with dyslipidemia.Health Condition 1: E785- Hyperlipidemia, unspecified
CTRI/2024/07/070696Dr Shivam Yadav